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Invasive bacterial disease occurs frequently among na-
tive populations in the Arctic. Although a variety of bacte-
ria are involved in invasive bacterial disease in Greenland, 
Streptococcus pneumoniae, Escherichia coli, Staphylococ-
cus aureus, and other staphylococci are responsible for 
most cases (69%); incidence varies according to region and 
ethnicity.
T
he incidence of invasive disease caused by Streptococ-
cus pneumoniae and several other bacteria is mark-
edly higher in the Inuit populations of Alaska, Canada, and 
Greenland than in the non-Inuit populations of the same 
areas (1–3). The clinical extent of invasive disease caused 
by S. pneumoniae is severe; sequelae and case-fatality rates 
are almost 4× higher in native than in nonnative popula-
tions (1,4). As living conditions in Arctic populations in 
many ways are comparable, an international, cooperative, 
population-based surveillance for invasive diseases was es-
tablished in 1999 (5). The International Circumpolar Sur-
veillance (ICS) network registers invasive disease caused 
by S. pneumoniae, Haemophilus inﬂ  uenzae, Neisseria men-
ingitidis, group A streptococcus, and group B streptococcus 
in Alaska, Canada, Greenland, Iceland, northern Norway, 
Finland, and Sweden (5). 
In Greenland, case data for this network are reported 
from the treating doctors to the chief medical ofﬁ  cer of 
Greenland, who in turn reports to the ICS. However, the 
full picture of invasive bacterial disease in Greenland and 
the relative extent of disease caused by the 5 bacteria on 
which the ICS focuses have been unknown. Using labora-
tory data for a 10-year period in Greenland, we determined 
microbiologic causes of all invasive bacterial disease cases, 
microbial-speciﬁ  c trends in incidence over time, and varia-
tion in incidence by ethnicity and place of residency.
The Study
Greenland is inhabited by 56,000 persons. One fourth 
of the population lives in the capital, Nuuk, while the rest 
live in 16 towns and several settlements (the districts) scat-
tered around the island. Most persons (86%) are native 
Greenlanders; the rest are Caucasians, mostly Danes.
The laboratory at Queen Ingrids Hospital in Nuuk 
is the only microbiologic laboratory in Greenland. From 
laboratory ﬁ  les, we identiﬁ  ed all bacterial isolates from in-
vasive disease cases reported from January 1, 1995, though 
December 31, 2004. Demographic information about pa-
tients was obtained from the Civil Registration System of 
Greenland (6). Patients were categorized as Greenlanders 
if born in Greenland. Population data for incidence calcu-
lations were obtained from Statistics Greenland (7). The 
study was approved by the Commission for Scientiﬁ  c Re-
search in Greenland and reported to the Danish Data Pro-
tection Agency.
The laboratory used standard microbiologic methods. 
Until 1999, positive blood cultures were detected by us-
ing manual readings of blood culture bottles from Statens 
Serum Institut, Copenhagen, Denmark; beginning in 1999, 
the Bactec/Alert system (Organon Teknika, Turnhout, Bel-
gium) was used. In this system, 28–30 mL of blood is in-
jected directly into aerobic and anaerobic blood culture bot-
tles. Positive samples are characterized by Gram stain and 
cultured on blood agar supplemented with 5% deﬁ  brinated 
horse blood. Antigen/antibody tests are carried out for S. 
pneumoniae, N. meningitidis, and H. inﬂ  uenzae (the last 2 
only on cerebrospinal ﬂ  uid). Serotyping and group typing 
of S. pneumoniae and H. inﬂ  uenzae (Quellung method) and 
N. meningitidis (latex agglutination method) are performed 
at Statens Serum Institut. 
In total, 281 unique bacterial isolates from 254 epi-
sodes of invasive disease among 242 patients were identi-
ﬁ  ed: 72% of isolates in blood, 18% in cerebrospinal ﬂ  uid, 
and 10% in other samples. Of the 254 episodes, 47% oc-
curred among patients from the districts and 53% in pa-
tients from Nuuk. In 53% of episodes among patients from 
the districts, the ﬁ  rst microbiologic sample was taken after 
patient transfer to Nuuk. There were no differences in age, 
sex, ethnicity, underlying conditions, or mortality rates be-
tween district and Nuuk patients, but Greenlandic patients 
were younger (median 46 years, 25%–75% quartiles 17–59 
years) than Danish patients (median 57 years, 25%–75% 
quartiles 44–62 years) (p = 0.07).
Twenty different bacterial species or groups were iden-
tiﬁ  ed (22 isolates could not be characterized by species); 
the most numerous were S. pneumoniae, staphylococci, 
and E. coli (Table). For most bacteria, the invasive disease 
incidence varied by age in a U-shaped fashion (Figure 1). 
Most N. meningitidis cases (73%) occurred in children <10 
years of age, the 4 cases of H. inﬂ  uenzae group B infection 
occurred in children <1 year of age, and the youngest case-
patient with GBS was 12 years of age.
Incidence of invasive bacterial disease did not differ 
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according to patient sex but did differ markedly according 
to ethnicity and region. The age-adjusted rate ratio was 1.8 
(95% conﬁ  dence interval [CI] 1.1–2.9) for Greenlanders 
compared with Danes and 3.5 (95% CI 2.7–4.4) for persons 
living in Nuuk compared with persons living in the dis-
tricts, a rate ratio observed for almost all bacterial species.
The overall incidence of invasive bacterial isolates 
increased during the study period from 17.9/100,000 in 
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Table. Characteristics of 281 bacterial isolates and 242 case-patients from 254 episodes of invasive bacterial infection, Greenland,
1995–2004
Incidence* by sex 
Incidence* by ethnicity 
(place of birth) 
Incidence* by region 
(place of living) 
Bacterial class 
No.
isolates
Median
age, y 
(range) 
Overall
incidence*
M
(n = 129)
F
(n = 125)
Greenland 
(n = 235)
Denmark/
other
(n = 18) 
Nuuk
(n = 134)
Districts 
(n = 120)
Streptococcus spp. 
S. pneumoniae† 92 46
(0–76)
16.4 15.7 17.2 17.6 8.0 39.9 8.7
  Group A  
 streptococci 
55 8
(37–76) 
0.9 1.3 0.4 1.0 0 0.7 0.9
  Group B  
 streptococci 
54 3
(12–70) 
0.9 1.0 0.8 1.0 0 2.9 0.2
 Other‡  10 38
(6–67)
1.8 2.7 0.8 1.8 1.6 5.1 0.7
Staphylococcus spp. 
S. aureus§ 35 50
(0–90)
6.2 4.7 8.0 6.5 4.8 13.8 3.8
 Other¶  22 41
(0–70)
3.9 4.7 3.1 4.1 3.2 7.3 2.8
Enterococcus 
faecalis
84 5
(0–72)
1.4 2.0 0.8 1.4 1.6 2.9 0.9
Neisseria 
meningitidis#
15 5
(0–54)
2.7 2.3 3.1 3.0 0 5.8 1.6
Moraxella 
catarrhalis 
21 8
(0–36)
0.4 0 0.8 0.4 0 0.7 0.2
Haemophilus influenzae
 Type  b  40
(0–0)
0.7 0.7 0.8 0.8 0 0.7 0.7
 Non-b 10 22
(0–71)
1.8 1.3 2.3 2.0 0 2.9 1.4
Pseudomonas 
aeruginosa
24 5
(36–55) 
0.4 0.7 0 0.4 0 1.5 0
Enterobacteriaceae spp. 
Escherichia coli  44 58
(0–84)
7.8 7.7 8.0 7.9 8.0 14.5 5.7
Klebsiella
pneumoniae 
66 7
(22–74) 
1.1 1.0 1.1 1.0 1.6 2.9 0.5
Salmonella spp.  54 2
(12–51) 
0.9 1.0 0.8 0.6 3.2 2.2 0.5
Enterobacter
 cloacae 
17 20 . 2 0 . 30 0 . 2 0 0 0 . 2
Other
 Gram-positive   
 cocci** 
54 6
(4–65)
0.9 0.7 1.1 1.0 0 1.5 0.7
 Gram-positive   
 rods†† 
75 8
(13–72) 
1.2 1.3 1.1 1.4 0 2.2 0.9
 Gram-negative   
 rods‡‡ 
35 4
(13–72) 
0.5 0 1.1 0.6 0 0.7 0.5
Total  281 47
(0–90)
50.0 49.0 51.1 52.9 32.1 108.1 31.1
*Per 100,000 population.  
†Most numerous serotypes were 12F (9) and 22F (5); 41 isolates not were serotyped. Serotype distribution for 1996–2002 described in detail in (1).
‡Other hemolytic and nonhemolytic streptococci. 
§None of the S. aureus isolates were methicillin-resistant strains. 
¶S. epidermidis (6) and other non–S. aureus staphylococci. 
#Two isolates in group B, 4 in group C, and 9 not grouped. 
**S. mitis (1) and unspecified cocci. 
††Bacillus sp. (1), corynebacterium (1), Clostridium perfringens (2), Listeria monocytogenes (1), and Propionebacterium sp. (1). 
‡‡Bacteroides sp. (1) and unspecified rods.1995 to 79/100,000 in 2004; the most marked increase oc-
curred in 1997–1998, when incidence almost doubled. The 
increase occurred mainly in blood culture samples; cere-
brospinal ﬂ  uid samples remained constant over time. The 
increase in isolates from blood cultures occurred equally 
in Nuuk and in the districts and for most bacteria, although 
the incidence of N. meningitidis remained constant (Figure 
2). H. inﬂ  uenzae group B isolates were not identiﬁ  ed after 
1998 (childhood vaccination was introduced in 1997); the 
5 GAS isolates ﬁ  rst appeared in 2001–2004.
Conclusions
A variety of bacteria were found to be associated with 
invasive disease in Greenland. S. pneumoniae was the most 
commonly involved, conﬁ   rming the importance of this 
pathogen in native populations in the Arctic (1–3). However, 
the second and third most frequent invasive bacteria were 
E. coli and S. aureus, a ﬁ  nding which, to our knowledge, 
had not been described before in Greenland. In contrast, the 
5 bacteria included in the Circumpolar Surveillance System 
accounted for only 47% of microorganisms (5). Surveillance 
of these 5 bacteria is relevant, though, as they are all seri-
ous, potentially fatal diseases of infants or children and are 
associated with some form of preventive action (either vac-
cines or prophylaxis). S. aureus and E. coli are not amenable 
to simple speciﬁ  c public health actions, so surveillance for 
these infections is less useful. Evaluation of outcome and 
risk factors for S. aureus and E. coli in Arctic areas may lead 
to potential preventive or clinical care options.
Worldwide, microbiologic causes of bacteremia have 
shifted from gram-negative organisms being the most com-
mon in the 1970s to gram-positive organisms with coagu-
lase-negative staphylococci, S. aureus, and enterococci be-
ing the most frequent in the last part of the 20th century 
(8). Likewise, we found gram-positive bacteria in 67% of 
invasive disease cases and gram-negative bacteria (mostly 
Enterobacteriaceae) in 33% and increasing incidence of 
both gram-positive and gram-negative bacteria over the 
study period.
The overall incidence of invasive bacterial disease was 
3.5-fold higher among Nuuk patients than among district 
patients. Most likely this ﬁ  nding represents sampling bias; 
microorganisms sent from the districts are less likely to sur-
vive than samples taken in Nuuk, and district doctors may 
be less likely to submit samples than Nuuk doctors, given 
the longer time to receive test results. However, we cannot 
conﬁ  rm this explanation because of lack of information on 
the total number of submitted samples. Furthermore, the 
39% higher average income in Nuuk compared with the 
rest of Greenland makes a Nuuk/district invasive disease 
incidence rate ratio of 3.5:1 less likely (7). The difference 
suggests that the true invasive disease rates in Greenland 
may be much higher than those found in this study or re-
ported to ICS. A clear recommendation from this study is 
to develop a more accessible, rapid, and reliable diagnostic 
system for districts outside of Nuuk.
The lower age-adjusted invasive bacterial disease inci-
dence in Danes than Greenlanders may be explained by the 
“healthy worker effect.” Danes in general come to Green-
land to work and belong to higher social classes and live 
in better housing conditions than the general population of 
Greenland, factors that may reduce the risk for infection 
(9). Hence, although genetic factors may account for some 
of the difference, the difference is probably confounded by 
environmental and social factors.
The increase in invasive bacterial isolates during the 
study period most likely represents changes in submission 
or detection practices. The increase occurred almost exclu-
sively in blood cultures, and a new blood culture detection 
system was introduced in 1999. Similar ﬁ  ndings have been 
observed in Europe (10). These data may lead to improved 
surveillance of invasive bacterial disease in Greenland.
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Figure 1. Incidence by age, invasive bacterial disease, Greenland, 
1995–2004.
Figure 2. Incidence by year, invasive bacterial disease, Greenland, 
1995–2004.Invasive Bacterial Diseases, Greenland
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